KIZ OpenIR  > 科研部门  > 生物毒素与人类疾病(张云)
Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation
Zhang Yong1; Wang Y1,2; Xiang Y1; Lee WH1; Zhang Y*1; zhangy@mail.kiz.ac.cn
2012
发表期刊JOURNAL OF THROMBOSIS AND HAEMOSTASIS
卷号10期号:3页码:411-418
合作性质其它
摘要Background: Prohibitins (PHBs), comprising the two homologous members PHB1 and PHB2, are ubiquitously expressed and highly conserved. The membrane PHBs have been reported to be involved in typhoid fever, obesity, and cancer metastasis. Proteomic studies have revealed the presence of PHBs in human platelets, but the roles of PHBs during platelet aggregation are unknown.Objectives: To investigate the role of PHBs in platelet aggregation. Methods and results: PHB1 and PHB2 were detected on the surfaces of human platelets by flow cytometry and confocal microscopy. The PHBs were distributed in lipid rafts, as determined by sucrose density centrifugation. In addition, the PHBs were associated with protease-activated receptor1 (PAR1), as determined by Bm-TFF2 (a PAR1 agonist)-affinity chromatography, coimmunoprecipitation, and confocal microscopy. The platelet aggregation, aIIb beta 3 activation, granular secretion and calcium mobilization stimulated by low concentrations of thrombin (0.05 U mL-1) or PAR1-activating peptide (PAR1-AP) (20 mu m) were reduced or abolished as a result of the blockade of PHBs by anti-PHB antibodies or their Fab fragments; however, the same results were not obtained with induction by high concentrations of thrombin (0.6 U mL-1) or protease-activated receptor4-activating peptide (300 mu m). The calcium mobilization in MEG-01 megakaryocytes stimulated by PAR1-AP was significantly suppressed by PHB depletion with RNA interference against PHB1 and PHB2. Conclusions: PHBs are localized on the human platelet membrane and are involved in PAR1-mediated platelet aggregation. Until recently, PHBs were unknown as regulators of PAR1 signaling, and they may be effective targets for antiplatelet therapy.
关键词Platelets Prohibitin Protease-activated Receptor 1 Thrombin
资助者his work was supported by grants from the National Basic Research Program of China (973 Program, 2010CB529800) and the National Natural Science Foundation of China (NSFC-Yunnan joint funding U1132601, 30630014, and 30870304) to Y. Zhang. ; his work was supported by grants from the National Basic Research Program of China (973 Program, 2010CB529800) and the National Natural Science Foundation of China (NSFC-Yunnan joint funding U1132601, 30630014, and 30870304) to Y. Zhang. ; his work was supported by grants from the National Basic Research Program of China (973 Program, 2010CB529800) and the National Natural Science Foundation of China (NSFC-Yunnan joint funding U1132601, 30630014, and 30870304) to Y. Zhang. ; his work was supported by grants from the National Basic Research Program of China (973 Program, 2010CB529800) and the National Natural Science Foundation of China (NSFC-Yunnan joint funding U1132601, 30630014, and 30870304) to Y. Zhang.
收录类别SCI
语种英语
资助者his work was supported by grants from the National Basic Research Program of China (973 Program, 2010CB529800) and the National Natural Science Foundation of China (NSFC-Yunnan joint funding U1132601, 30630014, and 30870304) to Y. Zhang. ; his work was supported by grants from the National Basic Research Program of China (973 Program, 2010CB529800) and the National Natural Science Foundation of China (NSFC-Yunnan joint funding U1132601, 30630014, and 30870304) to Y. Zhang. ; his work was supported by grants from the National Basic Research Program of China (973 Program, 2010CB529800) and the National Natural Science Foundation of China (NSFC-Yunnan joint funding U1132601, 30630014, and 30870304) to Y. Zhang. ; his work was supported by grants from the National Basic Research Program of China (973 Program, 2010CB529800) and the National Natural Science Foundation of China (NSFC-Yunnan joint funding U1132601, 30630014, and 30870304) to Y. Zhang.
WOS记录号WOS:000300876600011
引用统计
被引频次:20[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.kiz.ac.cn/handle/152453/6933
专题科研部门_生物毒素与人类疾病(张云)
科研部门_动物模型与人类重大疾病机理重点实验室
通讯作者zhangy@mail.kiz.ac.cn
作者单位1.Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan
2.Graduate School of the Chinese Academy of Sciences, Beijing, China
推荐引用方式
GB/T 7714
Zhang Yong,Wang Y,Xiang Y,et al. Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS,2012,10(3):411-418.
APA Zhang Yong,Wang Y,Xiang Y,Lee WH,Zhang Y*,&zhangy@mail.kiz.ac.cn.(2012).Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation.JOURNAL OF THROMBOSIS AND HAEMOSTASIS,10(3),411-418.
MLA Zhang Yong,et al."Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation".JOURNAL OF THROMBOSIS AND HAEMOSTASIS 10.3(2012):411-418.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
2012051001.pdf(382KB)期刊论文出版稿开放获取CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang Yong]的文章
[Wang Y]的文章
[Xiang Y]的文章
百度学术
百度学术中相似的文章
[Zhang Yong]的文章
[Wang Y]的文章
[Xiang Y]的文章
必应学术
必应学术中相似的文章
[Zhang Yong]的文章
[Wang Y]的文章
[Xiang Y]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。